ClinCalc Pro
Menu
Pneumococcal vaccine (conjugate)

Pneumococcal polysaccharide conjugate vaccine (adsorbed)

Brand names: Prevenar 13, Vaxneuvance, Apexxnar

Adult dose

Dose: 0.5mL IM single dose (PCV13/15/20 per UK schedule); see Green Book
Route: IM
Frequency: per schedule

Clinical pearls

  • UK childhood immunisation schedule: PCV13 at 12 weeks and 1 year
  • Adults: at-risk groups per Green Book

Contraindications

  • Severe hypersensitivity to vaccine components

Side effects

  • Injection-site reactions
  • Fever
  • Irritability (paeds)
  • Drowsiness
  • Decreased appetite

Interactions

  • Immunosuppressives reduce response
  • Consider spacing from PPV23

Reference: BNF; UKHSA Green Book Ch.25; https://bnf.nice.org.uk/drugs/pneumococcal-polysaccharide-conjugate-vaccine-adsorbed/. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.